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Abstract—Current clinical standards in the endoscopic 
diagnosis of gastrointestinal diseases are primarily based on the 
use of optical systems. Ultrasound has established diagnostic 
credibility in the form of endoscopic ultrasound (EUS), however 
it is limited to examination of the upper gastrointestinal tract 
(oesophagus, stomach and upper (proximal) small bowel). Access 
to the remainder of the small bowel is currently limited to optical 
capsule endoscopes and a limited number of other modalities as 
these capsules are restricted to visual examination of the surface 
or mucosa of the gut wall. Ultrasound capsule endoscopy has 
been proposed to integrate microultrasound imaging capabilities 
into the existing capsule format and extend examination 
capabilities beyond the mucosa. 
To establish the ability of high frequency ultrasound to 
resolve the histological structure of the gastrointestinal tract, ex 
vivo scans of pig and human tissue were performed. This was 
done using 25 and 34 MHz single element, physically focused 
composite transducers mechanically scanned along the tissue. 
Tethered prototype devices were then developed with 30 MHz 
physically focused polyvinylidene fluoride (PVDF) single element 
transducers embedded for use in initial translational trials in the 
small bowel of porcine subjects. B-scan images from the ex vivo 
model validation and the in vivo trials are presented. 
 
Index Terms—endoscopy; microultrasound; prototyping; pre-
clinical; capsules; porcine; animal models 
I. INTRODUCTION 
Endoscopy and colonoscopy are the clinically accepted 
means of imaging and diagnosis of diseases of the 
gastrointestinal (GI) tract. Conventional endoscope based 
approaches combine optical and ultrasound imaging to allow 
both optical imaging of the surface and ultrasound facilitated 
full thickness imaging of the bowel wall and adjacent organs. 
These approaches are limited in their ability to access the full 
length of the GI tract either due to scope length or technical 
challenge. This is particularly true for the anatomically remote 
small bowel. Wireless video capsule endoscopy (VCE) 
devices have been designed to transit the entire GI tract, but 
they are currently limited to optical imaging of the superficial 
mucosal surface. Work is thus under way to implement 
additional capsule endoscopy (CE) functionality through the 
development of devices incorporating both optical and 
ultrasound imaging.  
Examining the literature for ultrasound imaging of the small 
bowel, it can be seen that the current clinical standard for 
small bowel imaging is based on external (transabdominal) 
ultrasound systems at standard clinical frequencies (≤15 MHz) 
[1]–[3]. Some internal imaging has been achieved using EUS 
and double-balloon enteroscopy [4], however, work at  higher 
ultrasound frequencies (microultrasound) is extremely limited 
[5], [6]. The Sonopill project looks to address this limitation 
with the development of an ultrasound capsule endoscopy 
(USCE) device operating in the microultrasound range.  
As the proposed device is highly complex, there was a need 
for both benchtop and in vivo models for the validation of the 
proposed imaging frequencies and configurations. To this end, 
a suitable animal model was sought that would match human 
tissue characteristics at the histologic level and allow device 
prototyping in translational trials. 
This work was supported by the UK Engineering and Physical Sciences 
Research Council (EPSRC) under the grant number EP/K034537/1; 
EP/K034537/2 and entitled Sonopill. 
This paper presents the evaluation of a porcine model for 
microultrasound imaging in the GI tract for use in benchtop 
and translational trials and the results of preliminary trials of 
USCE devices in the model. 
II. MICROULTRASOUND IMAGING OF THE 
GASTROINTESTINAL TRACT 
  
Microultrasound imaging has been proposed as a viable 
solution to the clinical need for real-time, non-invasive 
monitoring of the GI tract [3] given its ability to distinguish 
sub-millimeter tissue characteristics. The thinnest layers of 
human GI tissue measured were on the order of 100 µm [7], 
mandating ultrasound centre frequencies above 20 MHz to 
fully visualise the layer structure and permit accurate 
diagnosis of pathology in those layers. While microultrasound 
faces reduced penetration depths due to increased attenuation 
when compared to conventional frequencies, GI tissue only 
requires penetration of 1-3 cm provided that the ultrasound 
probe can be brought into proximity with the tissue under 
observation. This matches well with the proposed capsule-
based modality, but raises the question of suitable tissue 
analogues for the verification of capsule prototypes prior to 
clinical trials. To assess the suitability of the porcine model 
for this modality, human and porcine GI tissue samples were 
obtained and mechanically scanned with microultrasound 
transducers, then clinically assessed. All ex vivo scans 
reported here were performed with a previously established 
mechanical scanning system [8] in conjunction with 25 and 34 
MHz single-element, physically focused piezocomposite 
transducers (AFM Ltd, Birmingham, UK). 
A. Human Imaging 
To establish a baseline for the analysis of the suitability of 
the selected animal model, initial ex vivo scans were 
performed on ethically obtained human colon tissue at 
multiple microultrasound frequency ranges. The human tissue 
sample trial was approved by the Tissue Bank Committee and 
supplied by the Tayside Biorepository (Study Number: 
TR000442 Microultrasound characterization of 
gastrointestinal tissue). 
Tissue was collected post-surgical excision and delivered to 
pathology for processing. The excised colon was transected 
along the long axis and inspected. A presumed healthy 3×3 cm 
sample from each colon was supplied by the pathologist for 
mechanical scanning with single-element microultrasound 
transducers.   
Samples were taken from areas remote (~20 cm) to the 
primary tumor and remained unfixed during the entire 
experiment. Prior to scanning, the sample was pinned (25G 
microlance, Becton-Dickson) on 1% agar (Fisher) above 
embedded sound absorber within a plastic dish. A thin layer of 
ultrasound coupling gel (1 - 2 mm) separated the sample from 
the agar thus ensure distinct ultrasound signals. The dish was 
then filled with degassed phosphate buffered saline (dPBS). A 
sufficient fluid level above the sample was ensured to provide 
sufficient acoustic coupling throughout the scanning 
procedure. 
Scanning was done running proximal to distal along the 
long axis of the sample. Scans in the X direction (proximal to 
distal) were performed using 0.02 mm steps for a total of 15 
mm. Each X slice was separated by a 1 mm Y step (left to 
right on the short axis). This was performed to provide at least 
one viable scan slice per sample. All collected data was then 
stored using custom LabVIEW software (National 
Instruments, Austin, TX, USA) and post-processed using 
MATLAB (Mathworks, Natick, MA, USA) to generate grey-
scale B-scans for comparisons. 
B. Porcine Model 
As an established model of the human GI tract in regards to 
histological similarity, pigs were chosen as the model for 
translational work. They are well suited both in their 
comparative physical dimensions as well as the availability 
and ethical considerations of obtaining access to both in vivo 
and ex vivo tissue from the selected animal. Porcine tissue is 
well-matched to the human GI tract due to their similarity of 
diet and lifespan [9] and it has the additional advantage of 
healthy tissue being readily available ex vivo.  
Porcine oesophageal tissue samples were sourced from an 
abattoir (Medical Meat Supplies Ltd, Oldham, UK). Samples 
were supplied frozen and considered fit for human 
consumption, so they were assumed to be a suitable to provide 
a healthy baseline. To prepare for scanning, sealed samples 
were thawed for 20 minutes under running tap water. They 
were then rinsed prior to being transected down the 
longitudinal axis, allowing the tissue to be opened up and 
placed on the same agar substrate as described earlier. The 
tissue was prepared with the same approach as that used in the 
human tissue scans i.e. head to toe LabVIEW and MATLAB 
were again used to store and process the data, and the B-scans 
were compared to the human scans and assessed by a clinician 
for diagnostic quality and alignment of the porcine and human 
anatomy. 
III. TRANSLATIONAL TRIALS 
Once the porcine model had been established, preliminary 
translational trials were undertaken with a set of tethered 
ultrasound capsules which were previously developed [10], 
featuring four 30 MHz PVDF single element transducers and 
an internal receive amplification circuit comprising 4 channel 
transmit/receive protection (MD0101, Microchip Technology, 
Chandler, USA) and operation amplifiers (ADA4807, Analog 
Devices, Norwood, USA) set for 12 dB of gain. Multiple 
identical capsules were prepared prior to the trials, with 2 
capsules being used in the final experiment. System control 
was achieved with a combination of custom Labview software 
in conjunction with a myRIO acquisition device (myRIO-
1900, National Instruments Inc., Austin, TX, USA). A 
commercial ultrasound pulser/receiver (DPR500, JSR 
Ultrasonics, Pittsford, USA) and a 2 GS/s oscilloscope 
(MDO3024, Tektronix, Beaverton, USA) were used to fire the 
transducers and observe the returning echoes. All protocols 
were repeated for both capsules on both animals. 
The described study was conducted under Home Office 
(UK) License (PPL: 70/8812) in accordance with the Animal 
(Scientific Procedures) Act 1986. Two female Landrace pigs, 
aged 4 months, were supplied by a local breeder/supplier. The 
pigs were maintained in groups of no less than two animals in 
licensed housing (PEL 60/4604), bedded on straw and fed 
‘ABN Pig Rearer Pellets’ ad lib. Environmental variables 
were maintained within the limits detailed by PEL.  Food was 
withheld for 12 hours before anesthesia, but access to water 
was maintained until pre-anesthetic medication. This was: 
azaperone (1 mgkg-1; “Stresnil 40 mg/ml Solution for 
Injection”, Elanco Animal Health, Hampshire), ketamine (2 
mgkg-1; “Ketamidor 100 mg/ml Solution for Injection”, 
Chanelle UK, Berkshire), midazolam (0.5 mgkg-1; “Hypnovel 
10mg/2ml Solution for Injection”, Roche, Hertfordshire) and 
morphine (0.25 mgkg-1; “Morphine Sulphate 30mg/ml”, 
Martindale Pharmaceuticals, Buckinghamshire) combined in 
one syringe and injected intramuscularly. Anesthesia was 
induced with isoflurane (“Isoflo” Zoetis, Surrey), vaporized in 
oxygen and nitrous oxide administered via a Bain breathing 
system and facemask. A cannula was placed in the auricular 
vein.  Complications with capsule introduction arising from 
the endotracheal tube were circumvented by the oro-
oesophageal insertion of a modified, wide diameter 
endotracheal tube.   
Access to the remote small bowel was enabled via an 
artificially created stoma under general anesthesia 
immediately prior to the experiment. The experiment and 
subject were monitored throughout the experiment by an 
experienced veterinary anesthetist. When the experiments 
were complete, the animals were euthanized without recovery 
using pentobarbital. 
During the study, each capsule was introduced 60 cm into 
the small bowel via the stoma and moisture levels were 
maintained with a saline drip placed in the mouth of the 
stoma. Each transducer was then activated in sequence and the 
capsule pulled back 12 cm by the certified operator over the 
course of 30 seconds. Following each pull-back, the capsule 
was returned to the original position with the assistance of 
physical marks on the tether of the capsule. The protocol was 
then repeated for each transducer three times, then for the 
other capsule.  
IV. RESULTS 
A. Human Tissue 
High quality tissue B-scan images were obtained from the 
human colon scans at 25 MHz (Fig. 1) and 34 MHz (Fig. 2), 
with good layer definition and tissue texture having been 
noted by the clinical team member. Individual layers were 
noted at approximately 1 mm in thickness, with the full 
 
Fig. 1 Human colon mechanically scanned with a 25 MHz composite 
transducer physically focused at 8 mm. Scan is from the proximal colon 
(0 mm) to the distal colon (15 mm) 
 
Fig. 2 Human colon mechanically scanned with a 34 MHz composite 
transducer physically focused at 6.5 mm. Scan is from the proximal colon 
(0 mm) to the distal colon (15 mm) 
 
 
Fig. 4 Porcine oesophagus scanned with a 34 MHz composite transducer 
physically focused at 6.5 mm. Scan is from the oesophageal mouth (0 
mm) towards the stomach (15 mm). 
 
 
Fig. 3 Porcine oesophagus scanned with a 25 MHz composite transducer 
physically focused at 8 mm. Scan is from the oesophageal mouth (0 mm) 
towards the stomach (15 mm). 
thickness of the tissue measuring approximately 4.5 mm. 
These were then treated as benchmarks for the assessment of 
the porcine tissue images. 
B. Porcine ex vivo Tissue 
Grey-scale images were obtained from the porcine small 
bowel at both 25 MHz (Fig. 3) and 34 MHz (Fig. 4) and 
compared to the human tissue scans in Fig. 1 and 2. Good 
agreement was noted between the physical layer thicknesses 
as well as in relative tissue contrast and image quality.  
The esophageal samples do show thinner upper tissue layers 
when compared to the human colon samples, however this 
variance is in keeping with normal anatomical variation for 
these tissue types [9]. 
C. Porcine in vivo 
Good acoustic coupling was achieved in the small bowel 
during in vivo trials with the saline drip acting as the sole 
artificial coupling agent. As seen in Fig 5, layer differentiation 
was successfully achieved and tissue dimensions matched 
those seen in the ex vivo scans were observed. Degradation of 
the image and layer structure is noticeable, in comparison to 
Fig. 3 and 4, at least some of which can be attributed to the 
reduced ultrasound power provided by the PVDF transducers. 
Examination of the frequency content of the in vivo data also 
shows attenuation in the higher frequency bands, with a 
resulting downshift in the centre frequency of the echoes. This 
may reflect increased frequency-dependent attenuation in the 
live model.  
V. CONCLUSIONS AND FUTURE WORK 
This study was able to establish good agreement between 
human GI tissue and porcine GI tissue for microultrasound 
frequencies of 25 and 34 MHz. Similarity of layer structure 
and thickness was observed and clinical assessment was that 
the porcine tissue offered a suitable and ethical analogue for 
human tissue for the purpose of assessment of 
microultrasound scanning. Based on the assessment of the ex 
vivo tissue and in vivo experiments, microultrasound can 
provide a viable means of subsurface gut (GI) examination in 
capsule form. 
Microultrasound images were subsequently successfully 
obtained in the porcine small bowel during initial trials of the 
capsule endoscopy prototype using saline as a coupling agent. 
This represents the first in vivo trial of a capsule-based 
ultrasound endoscopy prototype and validates both the device 
design concept as well as the ability of the selected frequency 
range to differentiate the tissue layers. Future work will 
examine the extension of this work to linear arrays and the 
integration of additional modalities into the capsules to better 
replicate the desired final device. Additional receive signal 
processing will be integrated within the capsule to alleviate 
some of the signal loss seen in the in vivo experiments to date. 
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Fig. 5 Porcine small bowel tissue scan in vivo obtained with a 30 MHz 
PVDF transducer physically focused at 6 mm. Scan was obtained via a 
12 cm pullback through the small bowel accessed via a surgically 
inserted stoma. 
